Eddit
K |
K |
||
Zeile 3: | Zeile 3: | ||
*'''[[Unproven ideas]]''' | *'''[[Unproven ideas]]''' | ||
*'''[[Reviews on covid19 disease]]''' | *'''[[Reviews on covid19 disease]]''' | ||
+ | {{tp|p=32371564|t=2020. Clinical presentation and course of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32366502|t=2020. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies |pdf=|usr=}} | ||
+ | {{tp|p=32252141|t=2020. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19) |pdf=|usr=}} | ||
+ | {{tp|p=32252139|t=2020. Epidemiology and clinical features of coronavirus disease 2019 in children |pdf=|usr=}} | ||
+ | {{tp|p=32207680|t=2020. COVID-19: the new challenge for rheumatologists |pdf=|usr=}} | ||
+ | {{tp|p=32197957|t=ä. What Should Gastroenterologists and Patients Know About COVID-19?|pdf=|usr=}} | ||
+ | |||
*'''[[Research tools]]''' | *'''[[Research tools]]''' | ||
* | * | ||
*'''[[Structure of covid19]]''' | *'''[[Structure of covid19]]''' | ||
*'''[[Target binding and uptake]]''' | *'''[[Target binding and uptake]]''' | ||
+ | {{tp|p=32220422|t=2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections |pdf=|usr=}} | ||
+ | |||
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
*'''[[Secretion and shedding]]''' | *'''[[Secretion and shedding]]''' | ||
*'''[[Innate sensing]]''' | *'''[[Innate sensing]]''' | ||
*'''[[Immunology]]''' | *'''[[Immunology]]''' | ||
+ | {{tp|p=32339487|t=2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China |pdf=|usr=}} | ||
+ | {{tp|p=32333860|t=2020. Presepsin in risk stratification of SARS-CoV-2 patients |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | ||
+ | {{tp|p=32145275|t=2020. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis |pdf=|usr=}} | ||
+ | {{tp|p=32348783|t=2020. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis |pdf=|usr=}} | ||
+ | {{tp|p=32202240|t=2020. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?|pdf=|usr=}} | ||
+ | |||
*'''[[Microvascular]]''' | *'''[[Microvascular]]''' | ||
* | * | ||
Zeile 18: | Zeile 35: | ||
*'''[[ARDS]]''' | *'''[[ARDS]]''' | ||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
+ | {{tp|p=32250159|t=2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients |pdf=|usr=}} | ||
+ | |||
*'''[[Hematology]]''' | *'''[[Hematology]]''' | ||
+ | {{tp|p=32178975|t=ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis |pdf=|usr=}} | ||
+ | |||
*'''[[Heart]]''' | *'''[[Heart]]''' | ||
+ | {{tp|p=32371557|t=2020. SARS-CoV-2 and myocardial injury: Few answers, many questions |pdf=|usr=}} | ||
+ | |||
*'''[[Neurology, ophthalmology, orl]]''' | *'''[[Neurology, ophthalmology, orl]]''' | ||
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
*'''[[Gastroenterology, hepatology]]''' | *'''[[Gastroenterology, hepatology]]''' | ||
+ | {{tp|p=32371556|t=2020. Hyperglycemia management in the critically ill patient with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32205220|t=ä. Don t Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19) |pdf=|usr=}} | ||
+ | {{tp|p=32278065|t=ä. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management |pdf=|usr=}} | ||
+ | {{tp|p=32334083|t=ä. Current Knowledge and Research Priorities in the Digestive Manifestations of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32311512|t=ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32283325|t=ä. Clinical Features of COVID-19-Related Liver Damage |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Kidney, urology]]== | *'''[[Kidney, urology]]== | ||
* | * | ||
*'''[[Pathobiology]]''' | *'''[[Pathobiology]]''' | ||
+ | {{tp|p=32334082|t=ä. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection |pdf=|usr=}} | ||
+ | |||
*'''[[Disease Models]]''' | *'''[[Disease Models]]''' | ||
*'''[[Similar diseases and pathomechanisms]]''' | *'''[[Similar diseases and pathomechanisms]]''' | ||
* | * | ||
*'''[[Diagnosis (Laboratory)]]''' | *'''[[Diagnosis (Laboratory)]]''' | ||
+ | {{tp|p=32360478|t=2020. Emerging key laboratory tests for patients with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32077933|t=ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32154877|t=ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception |pdf=|usr=}} | ||
+ | {{tp|p=32246822|t=ä. Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads |pdf=|usr=}} | ||
+ | {{tp|p=32353116|t=ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything |pdf=|usr=}} | ||
+ | {{tp|p=32343775|t=ä. SARS-CoV-2 Serology: Much Hype, Little Data |pdf=|usr=}} | ||
+ | {{tp|p=32315390|t=ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform |pdf=|usr=}} | ||
+ | {{tp|p=32282874|t=ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2) |pdf=|usr=}} | ||
+ | {{tp|p=32031590|t=ä. Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV) |pdf=|usr=}} | ||
+ | {{tp|p=32229107|t=2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient |pdf=|usr=}} | ||
+ | {{tp|p=32031583|t=ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia |pdf=|usr=}} | ||
+ | {{tp|p=32156607|t=ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 |pdf=|usr=}} | ||
+ | {{tp|p=32343948|t=2020. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study |pdf=|usr=}} | ||
+ | {{tp|p=32335089|t=ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories |pdf=|usr=}} | ||
+ | {{tp|p=32315614|t=2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients |pdf=|usr=}} | ||
+ | {{tp|p=32295319|t=2020. Innovative screening tests for COVID-19 in South Korea |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Diagnosis (Lung CT, Sonography)]]''' | *'''[[Diagnosis (Lung CT, Sonography)]]''' | ||
*'''[[Diagnosis (other modalities)]]''' | *'''[[Diagnosis (other modalities)]]''' | ||
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
*'''[[Respiration mgmt]]''' | *'''[[Respiration mgmt]]''' | ||
+ | {{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}} | ||
+ | |||
*'''[[Risk and special populations]]''' | *'''[[Risk and special populations]]''' | ||
+ | {{tp|p=32371563|t=2020. Asthma increases risk of severity of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32360479|t=ä. 2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases |pdf=|usr=}} | ||
+ | {{tp|p=32360811|t=ä. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts |pdf=|usr=}} | ||
+ | {{tp|p=32334081|t=ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
*'''[[Case series]]''' | *'''[[Case series]]''' | ||
+ | {{tp|p=32308494|t=2020. Epidemiologic and Clinical Characteristics of 26 Cases of COVID-19 Arising from Patient-to-Patient Transmission in Liaocheng, China |pdf=|usr=}} | ||
+ | |||
* | * | ||
*'''[[Trials]]''' | *'''[[Trials]]''' | ||
*'''[[Candidate Compounds Covid19]]''' | *'''[[Candidate Compounds Covid19]]''' | ||
+ | {{tp|p=32371558|t=2020. Hydroxychloroquine use in the COVID-19 patient |pdf=|usr=}} | ||
+ | {{tp|p=32272008|t=2020. Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2 |pdf=|usr=}} | ||
+ | {{tp|p=32337664|t=ä. Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia |pdf=|usr=}} | ||
+ | {{tp|p=32359035|t=2020. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Remission, recurrence and persistence]]''' | *'''[[Remission, recurrence and persistence]]''' | ||
+ | {{tp|p=32311512|t=ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19 |pdf=|usr=}} | ||
+ | |||
*'''[[The morbid survivor]]''' | *'''[[The morbid survivor]]''' | ||
*'''[[Biophysics of aerosols]]''' | *'''[[Biophysics of aerosols]]''' | ||
Zeile 47: | Zeile 116: | ||
* | * | ||
*'''[[Running your hospital]]''' | *'''[[Running your hospital]]''' | ||
+ | {{tp|p=32371561|t=2020. Pulmonary function testing precautions in a time of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32371560|t=2020. PAP therapy increases the risk of transmission of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32252508|t=2020. Sharing Our Experience of Operating an Endoscopy Unit in the Midst of a COVID-19 Outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32371164|t=ä. RECOMMENDATIONS FOR ESSENTIAL ESOPHAGEAL PHYSIOLOGICTESTING DURING THE COVID-19 PANDEMIC |pdf=|usr=}} | ||
+ | {{tp|p=32304737|t=ä. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Mental aspects of health professionals]]''' | *'''[[Mental aspects of health professionals]]''' | ||
*'''[[Socio-psychiatric aspects of the status hygienicus]]''' | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | ||
+ | {{tp|p=32371559|t=2020. Helping children cope with the COVID-19 pandemic |pdf=|usr=}} | ||
+ | |||
*'''[[Avoiding clinical medicine in other diseases]]''' | *'''[[Avoiding clinical medicine in other diseases]]''' | ||
*'''[[Occupational medicine, workplace security and status hygienicus]]''' | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
Version vom 19. Mai 2020, 10:05 Uhr
32371564 2020. Clinical presentation and course of COVID-19
32366502 2020. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies
32252141 2020. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)
32252139 2020. Epidemiology and clinical features of coronavirus disease 2019 in children
32207680 2020. COVID-19: the new challenge for rheumatologists
32197957 ä. What Should Gastroenterologists and Patients Know About COVID-19?
32220422 2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32333860 2020. Presepsin in risk stratification of SARS-CoV-2 patients
32145275 2020. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
32348783 2020. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
32202240 2020. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
- Microvascular
- Early symptoms
- Systemic disease, any manifestations
- ARDS
- Pulmonary embolism, coagulation
32250159 2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients
32178975 ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
32371557 2020. SARS-CoV-2 and myocardial injury: Few answers, many questions
32371556 2020. Hyperglycemia management in the critically ill patient with COVID-19
32205220 ä. Don t Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)
32278065 ä. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management
32334083 ä. Current Knowledge and Research Priorities in the Digestive Manifestations of COVID-19
32311512 ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19
32283325 ä. Clinical Features of COVID-19-Related Liver Damage
32334082 ä. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
32360478 2020. Emerging key laboratory tests for patients with COVID-19
32077933 ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak
32154877 ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception
32246822 ä. Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads
32353116 ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything
32343775 ä. SARS-CoV-2 Serology: Much Hype, Little Data
32315390 ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform
32282874 ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2)
32031590 ä. Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV)
32229107 2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient
32031583 ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
32156607 ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020
32343948 2020. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
32335089 ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories
32315614 2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients
32295319 2020. Innovative screening tests for COVID-19 in South Korea
- Diagnosis (Lung CT, Sonography)
- Diagnosis (other modalities)
- Clinical guidelines and advice
- Respiration mgmt
32371555 2020. Utility of extracorporeal membrane oxygenation in COVID-19
32371563 2020. Asthma increases risk of severity of COVID-19
32360479 ä. 2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases
32360811 ä. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts
32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32308494 2020. Epidemiologic and Clinical Characteristics of 26 Cases of COVID-19 Arising from Patient-to-Patient Transmission in Liaocheng, China
32371558 2020. Hydroxychloroquine use in the COVID-19 patient
32272008 2020. Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
32337664 ä. Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
32359035 2020. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19
32311512 ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19
- The morbid survivor
- Biophysics of aerosols
- Other routes of infection
- Passive protective equipment
- Running your hospital
32371561 2020. Pulmonary function testing precautions in a time of COVID-19
32371560 2020. PAP therapy increases the risk of transmission of COVID-19
32252508 2020. Sharing Our Experience of Operating an Endoscopy Unit in the Midst of a COVID-19 Outbreak
32371164 ä. RECOMMENDATIONS FOR ESSENTIAL ESOPHAGEAL PHYSIOLOGICTESTING DURING THE COVID-19 PANDEMIC
32304737 ä. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic
32371559 2020. Helping children cope with the COVID-19 pandemic
- Avoiding clinical medicine in other diseases
- Occupational medicine, workplace security and status hygienicus
- Economic aspects of the status hygienicus
- Educational aspects of the status hygienicus
- Host, vector, one health, atmospheric aspects
- Origin of Covid19
- Epidemiology
- Failure of politics and public health guidance
- Failure of executive measures
- Political abuse of Covid19
- Lost people
- Lost civilization
- History of covid19 exploration
- Current state of coviki.org
- PubMed selected papers unsorted to be listed in contents topics
- coviki state of development
- misc.